Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia

Simple item page
dc.contributor.authorCourtney A.
dc.contributor.authorTriwongwarant D.
dc.contributor.authorChim I.
dc.contributor.authorEisman S.
dc.contributor.authorSinclair R.
dc.contributor.otherMahidol University
dc.date.accessioned2023-11-22T18:01:59Z
dc.date.available2023-11-22T18:01:59Z
dc.date.issued2023-01-01
dc.identifier.citationExpert Opinion on Pharmacotherapy (2023)
dc.identifier.doi10.1080/14656566.2023.2280630
dc.identifier.eissn17447666
dc.identifier.issn14656566
dc.identifier.scopus2-s2.0-85176586771
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/91137
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleEvaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
dc.typeEditorial
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85176586771&origin=inward
oaire.citation.titleExpert Opinion on Pharmacotherapy
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationUniversity of Melbourne
oairecerif.author.affiliationFaculty of Medicine, Nursing and Health Sciences
oairecerif.author.affiliationSinclair Dermatology

Files

Collections

Scopus 2023